Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Top Sell

Security Buy Sell Buy (1M) ▲ Sell (1M) Price Target price Potential
Viking Therapeutics Inc 4 1 0 1 €49.45 - -
Enlivex Therapeutics Ltd. 0 1 0 0 €1.10 - -
Organovo Holdings Inc. 0 9 0 1 €0.50 - -
Fate Therapeutics Inc. 3 3 0 0 €3.16 €7.31 131.049%
Glycomimetics Inc. 3 7 0 4 €0.14 €9.13 6424.714%
Cara Therapeutics Inc. 10 7 0 3 €0.29 €4.61 1468.593%
Trevena Inc. 2 23 0 2 €0.15 €6.48 4136.601%
Cytomx Therapeutics Inc 2 1 0 0 €1.08 €50.00 4521.072%
Atara Biotherapeutics Inc. 2 2 0 0 €0.37 €3.00 716.549%
Coherus Bioscien. 0 2 0 0 €1.19 - -
Xenon Pharmaceuticals Inc. 1 1 0 0 €36.00 €50.00 38.889%
Bellicum Pharmaceuticals Inc. 0 10 0 0 €0.064 - -
Minerva Neurosciences Inc. 0 10 0 1 €2.32 - -
Salarius Pharmaceuticals Inc. 0 1 0 0 €0.39 - -
Rocket Pharmaceuticals Inc 2 1 0 0 ? €32.00 94.175%
Agenus Inc. 4 2 1 0 €0.41 €37.02 8846.834%
Aspira Womens Health Inc. 1 1 1 0 €0.83 €4.99 501.494%
Intellia Therapeutics Inc 15 1 2 0 €18.85 €60.53 221.189%
Syros Pharmaceuticals Inc. 9 1 2 0 €1.41 €12.01 751.454%
Karyopharm Therapeutics Inc. 8 1 3 0 €0.68 €5.49 711.709%